Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pavmed Inc
(NQ:
PAVM
)
0.7350
+0.0508 (+7.42%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pavmed Inc
< Previous
1
2
3
Next >
PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study
March 24, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
March 23, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
March 17, 2022
From
PAVmed Inc.
Via
Business Wire
PAVmed Appoints Shaun O’Neil as Chief Operating Officer
February 24, 2022
From
PAVmed Inc.
Via
Business Wire
Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors
February 15, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference
February 10, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team
January 12, 2022
From
PAVmed Inc. and Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference
January 06, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth
December 01, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
November 17, 2021
From
Lucid Diagnostics Inc. PAVmed Inc.
Via
Business Wire
PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results
November 16, 2021
From
PAVmed Inc. and Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
November 11, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021
November 03, 2021
From
PAVmed Inc. and Lucid Diagnostics Inc.
Via
Business Wire
Veris Health Showcased in PAVmed Digital Health Virtual Investor Event
October 29, 2021
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics’ EsoGuard Esophageal DNA Test Wins “Diagnostics Innovation of the Year” Award
October 28, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Digital Health Subsidiary Veris Health Appoints Sunny Webb as Chief Technology Officer
October 25, 2021
From
PAVmed Inc.
Via
Business Wire
ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
October 21, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
October 21, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
October 18, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Announces Pricing of Initial Public Offering
October 13, 2021
From
PAVmed Inc.
Via
Business Wire
PAVmed Acquires EsophaCap Manufacturer CapNostics LLC
October 07, 2021
From
PAVmed Inc.
Via
Business Wire
PAVmed to Host Digital Health Virtual Investor Event
September 30, 2021
From
PAVmed Inc.
Via
Business Wire
PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering
September 23, 2021
From
PAVmed, Inc.
Via
Business Wire
PAVmed Subsidiary Veris Health Joins Microsoft for Startups Global Program and Engages Loka as Software Development Partner
September 21, 2021
From
PAVmed Inc.
Via
Business Wire
PAVmed to Participate in September Investor and MedTech Conferences
September 07, 2021
From
PAVmed Inc.
Via
Business Wire
PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results
August 12, 2021
From
PAVmed Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Launches First Lucid Test Centers
August 10, 2021
From
PAVmed Inc.
Via
Business Wire
PAVmed to Present at the 41st Annual Canaccord Genuity Growth Conference
August 05, 2021
From
PAVmed Inc.
Via
Business Wire
Global Industry Executive Aster Angagaw Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
August 03, 2021
From
PAVmed Inc.
Via
Business Wire
CORRECTING and REPLACING PAVmed to Hold Business Update Conference Call on August 12, 2021
August 02, 2021
From
PAVmed Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.